supported by a research grant from the Capital health development research project (grant number:2020-1-3011);a grant from the Beijing Youan Hospital,Capital Medical University in 2018 (grant number:YNKTTS20180105);a grant from the Beijing Municipal Administration of Hospitals Incubating Program in 2018 (grant number:PX2018058).
Background and Aims:Decompensated cirrhotic patients with hepatitis C(HCV)are often under-represented in clinical trials.We aimed to evaluate pooled data on the efficacy and safety of sofosbuvir(SOF)-based regimens in...
Hepatitis C virus(HCV)genotype(GT)3 infection is associated with a more rapid hepatic disease progression than the other genotypes.Hence,early HCV clearance slows down the disease progression and is important for impr...
Background and Aims:The current paradigm of specialist physician-managed treatment of chronic hepatitis C virus infection(HCV)is inefficient in absorbing the approximately 3 million patients awaiting treatment in the ...